LUX biotechnology announces appointment to Board of Directors

Edinburgh 20th July 2007 - LUX biotechnology limited (LUX), a specialist developer of light based detection technologies, today announced that Mr Bob Will has been unanimously appointed to its Board of Directors.

Mr. Will joins the Lux Board following a successful career in the oil and gas industry that spans 31 years and many international assignments. Mr. Will played a key role in the development of the cased hole division of the Expro Group, an oilfield services company, initiating and managing operational and cultural change to transform the organisation into a technology based service provider, expanding its global reach along with a 6 fold increase in turnover to £120 million+. He has experience as a company director and founder of SCS Ltd., which applied novel technologies from other sectors to oilfield operations and as Managing Director of Multiline Services helped Schlumberger to establish a leading presence in the fledgling memory logging sector. Previously Mr. Will had managed and run well operations in various global locations for Schlumberger Wireline & Testing, focussing on customer requirements and the introduction of new technologies to the cased hole sector of the industry.

Mr. Will’s appointment strengthens LUX biotechnology’s Board of Directors, where his expertise in the oil and gas industry will be directly applicable to LUX’s operations in that sector.

LUX’s core competencies lie in the rapid development and commercialization of technology with carefully selected partners. The Edinburgh based biotechnology company has seen rapid growth in the last 12 months along with demand for its solutions from diverse sectors including energy, chemical, water quality, medical and life science industries.

“I am delighted that Bob has agreed to join our board,” said Dr Jim Brown, chairman, LUX. “LUX has been collaborating in projects in the energy sector since 2004 and Bob’s experience and insight into the oil and gas industry will be an important contribution to our continuing involvement in this sector.”

According to Bob Will : “I am excited to be joining Jim and the rest of the LUX team. Their light based technologies will play an important role in many areas of industry but in my opinion none more so than in oil and gas. I hope that my involvement can help to accelerate LUX’s presence in the oilfield.”

-Ends-
Word count 387


NOTES TO EDITORS

About Mr. Bob Will
Bob Will joined the Expro Group in 1997, working first as a Cased Hole Business Development Manager and then as Cased Hole Director/Client Relationship Director, where he integrated the company’s cased hole services into a single customer-focussed division with a coherent R&D strategy and improved communications and marketing processes. Previously, Mr. Will had been Managing Director of Multi-Line Services Ltd., a Schlumberger subsidiary, and as Founder and Managing Director of S.C.S. Ltd an oilfield services and electronics company. Earlier in his career, Mr. Will worked in various International locations within Schlumberger Wireline & Testing.


About LUX biotechnology ltd
LUX biotechnology Ltd. is a specialist developer of detection technologies based on light. With a track record of working with major industry players and a strong, comprehensive in-house research team the company is geared towards efficient co-development of novel light based technological solutions to unmet needs in several industrial sectors. The company has ongoing co-development projects in the energy, chemical, water and life science sectors with potential application development in many more.

LUX was established in 2001 in Edinburgh, Scotland, UK. It is privately owned and is funded by Edinburgh based Archangel Informal Investments Ltd. It has won many awards for innovation, and has partnered with a number of companies and research groups worldwide. For more information visit: www.luxbiotech.com